Your browser doesn't support javascript.
loading
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Gangat, Naseema; Karrar, Omer; Iftikhar, Moazah; McCullough, Kristen; Johnson, Isla M; Abdelmagid, Maymona; Abdallah, Mostafa; Al-Kali, Aref; Alkhateeb, Hassan B; Begna, Kebede H; Mangaonkar, Abhishek; Saliba, Antoine N; Hefazi Torghabeh, Mehrdad; Litzow, Mark R; Hogan, William; Shah, Mithun; Patnaik, Mrinal M; Pardanani, Animesh; Badar, Talha; Murthy, Hemant; Foran, James; Palmer, Jeanne; Sproat, Lisa; Khera, Nandita; Arana Yi, Cecilia; Tefferi, Ayalew.
Afiliação
  • Gangat N; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Karrar O; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Iftikhar M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • McCullough K; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Johnson IM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Abdelmagid M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Abdallah M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Al-Kali A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Alkhateeb HB; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Begna KH; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Mangaonkar A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Saliba AN; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hefazi Torghabeh M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Litzow MR; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hogan W; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Shah M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Pardanani A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Badar T; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Murthy H; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Foran J; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
  • Palmer J; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Sproat L; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Khera N; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Arana Yi C; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Tefferi A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 99(2): 193-202, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38071734
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Adult / Aged / Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Compostos Bicíclicos Heterocíclicos com Pontes Limite: Adult / Aged / Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos